Meinert C
J R Soc Med. 2019; 112(12):503-511.
PMID: 31825277
PMC: 6909290.
DOI: 10.1177/0141076819890263.
Meinert C
J R Soc Med. 2019; 112(11):476-482.
PMID: 31710827
PMC: 7164314.
DOI: 10.1177/0141076819884869.
Chia C, Egan J, Ferrucci L
Circ Res. 2018; 123(7):886-904.
PMID: 30355075
PMC: 6205735.
DOI: 10.1161/CIRCRESAHA.118.312806.
Erpeldinger S, Rehman M, Berkhout C, Pigache C, Zerbib Y, Regnault F
BMC Endocr Disord. 2016; 16(1):39.
PMID: 27391319
PMC: 4939045.
DOI: 10.1186/s12902-016-0120-z.
Sardar P, Udell J, Chatterjee S, Bansilal S, Mukherjee D, Farkouh M
J Am Heart Assoc. 2015; 4(5).
PMID: 25944874
PMC: 4599400.
DOI: 10.1161/JAHA.114.001577.
Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: a systematic review.
Price H, Agnew M, Gamble J
BMJ Open. 2015; 5(3):e006341.
PMID: 25762229
PMC: 4360720.
DOI: 10.1136/bmjopen-2014-006341.
Prevalence of microvascular complications in newly diagnosed patients with type 2 diabetes.
Ali A, Iqbal F, Taj A, Iqbal Z, Amin M, Iqbal Q
Pak J Med Sci. 2013; 29(4):899-902.
PMID: 24353655
PMC: 3817776.
DOI: 10.12669/pjms.294.3704.
Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic review.
Boussageon R, Supper I, Erpeldinger S, Cucherat M, Bejan-Angoulvant T, Kassai B
BMC Med Res Methodol. 2013; 13:107.
PMID: 24229055
PMC: 3765855.
DOI: 10.1186/1471-2288-13-107.
Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
Hemmingsen B, Lund S, Gluud C, Vaag A, Almdal T, Hemmingsen C
BMJ. 2011; 343:d6898.
PMID: 22115901
PMC: 3223424.
DOI: 10.1136/bmj.d6898.
Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.
Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassai B
BMJ. 2011; 343:d4169.
PMID: 21791495
PMC: 3144314.
DOI: 10.1136/bmj.d4169.
Thiazolidinediones: a 2010 perspective.
Krishnaswami A, Ravi-Kumar S, Lewis J
Perm J. 2010; 14(3):64-72.
PMID: 20844707
PMC: 2937848.
DOI: 10.7812/TPP/09-052.
Glucose control and cardiovascular disease: is it important? No.
Conget I, Gimenez M
Diabetes Care. 2009; 32 Suppl 2:S334-6.
PMID: 19875576
PMC: 2811449.
DOI: 10.2337/dc09-S334.
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus.
Richter B, Bandeira-Echtler E, Bergerhoff K, Lerch C
Cochrane Database Syst Rev. 2008; (2):CD006739.
PMID: 18425967
PMC: 8985075.
DOI: 10.1002/14651858.CD006739.pub2.
Rosiglitazone for type 2 diabetes mellitus.
Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim S
Cochrane Database Syst Rev. 2007; (3):CD006063.
PMID: 17636824
PMC: 7389529.
DOI: 10.1002/14651858.CD006063.pub2.
Pioglitazone for type 2 diabetes mellitus.
Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim S
Cochrane Database Syst Rev. 2006; (4):CD006060.
PMID: 17054272
PMC: 8991699.
DOI: 10.1002/14651858.CD006060.pub2.
Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus.
Bonora E, Corrao G, Bagnardi V, Ceriello A, Comaschi M, Montanari P
Diabetologia. 2006; 49(5):846-54.
PMID: 16532323
DOI: 10.1007/s00125-006-0203-x.
Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP-NIDDM data.
Kaiser T, Sawicki P
Diabetologia. 2004; 47(3):575-580.
PMID: 14727025
DOI: 10.1007/s00125-003-1318-y.
Glomerulosclerosis in type 2 (non-insulin-dependent) diabetes mellitus: relationship to glycaemia in the University Group Diabetes Program (UGDP).
Carpenter A, Goetz F, Lecompte P, Williamson J
Diabetologia. 1993; 36(10):1057-63.
PMID: 8243855
DOI: 10.1007/BF02374499.
Effects of diet and exercise interventions on control and quality of life in non-insulin-dependent diabetes mellitus.
Kaplan R, Hartwell S, Wilson D, Wallace J
J Gen Intern Med. 1987; 2(4):220-8.
PMID: 3302144
DOI: 10.1007/BF02596443.
The prevalence of diabetic complications in Korea.
Lee T, Ryu H, Chung P, Lim W, Chung M
Korean J Intern Med. 1987; 2(1):42-7.
PMID: 3154816
PMC: 4534914.
DOI: 10.3904/kjim.1987.2.1.42.
